Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xintongshu Spray is a traditional Chinese medicine (TCM) product developed and manufactured by Huatuo Chinese Medicine (Huatuo Guoyao). It is an aerosol/spray formulation designed for sublingual administration to provide rapid relief from symptoms of coronary heart disease and angina pectoris. The preparation is based on the TCM principles of promoting blood circulation to remove stasis (huo xue hua yu) and regulating qi to alleviate pain (li qi zhi tong). It typically contains herbal extracts such as Salvia miltiorrhiza (Danshen) and Ligusticum chuanxiong (Chuanxiong), along with Borneol to facilitate rapid absorption through the oral mucosa. It is used for the emergency treatment and management of chest pain, chest tightness, and palpitations associated with qi stagnation and blood stasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xintongshu Spray.